In the past decade, immunotherapies have been developed that are capable of causing prolonged cancer regressions in selected patients with advanced metastatic disease. In the past year, attempts at the gene therapy of cancer have begun. These experimetnal cancer treatments deserve vigorous exploration.


Presented at the Symposium, “Discoveries and Opportunities in Cancer Research: A Celebration of the 50th Anniversary of the Journal Cancer Research,” May 15, 1991, during the 82nd Annual Meeting of the American Association for Cancer Research, Houston, TX.

This content is only available via PDF.